Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative-Reference-Cited by-同舟云学术

Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative

Published:2020-03-24 Issue:9 Volume:55 Page:1840-1843
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Anthias Chloe,Apperley Jane,Bloor Adrian,Byrne Jennifer^ORCID,Collin Matthew^ORCID,Crawley Charles,Craddock Charles,Finnegan Damian,Gilleece Maria^ORCID,Gribben John^ORCID,Hunter Ann,Hunter Hannah,Koh Mickey,Mackinnon Stephen,Malladi Ram,Marks David,McQuaker Grant,Nikolousis Manos,Orchard Kim,Pavlu Jiri,Peniket Andrew,Potter Mike,Potter Victoria,Robinson Stephen,Russell Nigel,Salim Rahuman,Snowden John^ORCID,Thomson Kirsty,Tholouli Eleni,Wilson Keith

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0870-0.pdf

Reference12 articles.

1. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 2001;97:3390–400.

2. Lush RJ, Haynes AP, Byrne J, Cull GM, Carter GI, Pagliuca A, et al. Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/− fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion. Cytotherapy. 2001;3:203–10.

3. Chakraverty R, Peggs K, Chopra R, Milligan DW, Kottaridis PD, Verfuerth S, et al. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood. 2002;99:1071–8.

4. Ho AY, Pagliuca A, Kenyon M, Parker JE, Mijovic A, Devereux S, et al. Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning. Blood. 2004;104:1616–23.

5. Basara N, Baurmann H, Kolbe K, Yaman A, Labopin M, Burchardt A, et al. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transpl. 2005;35:1011–8.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AML in the elderly—A global view;British Journal of Haematology;2023-10-11

2. Visions for a JACIE Quality Management System 4.0;Bone Marrow Transplantation;2021-09-29

3. Conditioning intensity before allogeneic haematopoietic stem cell transplantation: a quality control audit;British Journal of Haematology;2021-02-22